Contribution of the Indoor Environment Medical Advisor in the Management of Fibrosing Hypersensitivity Pneumonitis
Condition(s):Hypersensitivity PneumonitisLast Updated:September 28, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Hypersensitivity PneumonitisLast Updated:September 28, 2023Not yet recruiting
Condition(s):Hypersensitivity PneumonitisLast Updated:June 29, 2023Recruiting
Condition(s):Hypersensitivity PneumonitisLast Updated:December 22, 2023Recruiting
Condition(s):Hypersensitivity PneumonitisLast Updated:March 20, 2024Recruiting
Condition(s):Hypersensitivity PneumonitisLast Updated:November 30, 2022Recruiting
Condition(s):Sensitisation; Mold or Dust Allergy; Respiratory DiseaseLast Updated:January 30, 2023Not yet recruiting
Condition(s):Interstitial Lung Disease; Sarcoidosis; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Hypersensitivity PneumonitisLast Updated:November 28, 2023Recruiting
Condition(s):Pulmonary Fibrosis; SarcoidosisLast Updated:October 27, 2023Recruiting
Condition(s):Idiopathic Interstitial Pneumonia; Idiopathic Pulmonary Fibrosis; Nonspecific Interstitial PneumoniaLast Updated:March 27, 2024Recruiting
Condition(s):Right Ventricular FunctionLast Updated:November 18, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.